Home › Compare › CYBA vs JNJ

CYBA vs JNJ: Dividend Comparison 2026

CYBA yields 40000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBA wins by $134811832.11M in total portfolio value
10 years
CYBA
CYBA
● Live price
40000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$134811832.13M
Annual income
$22,334,973,273,625.93
Full CYBA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CYBA vs JNJ

📍 CYBA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBA + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CYBA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBA
Annual income on $10K today (after 15% tax)
$3,400,000.00/yr
After 10yr DRIP, annual income (after tax)
$18,984,727,282,582.04/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CYBA beats the other by $18,984,727,281,878.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBA + JNJ for your $10,000?

CYBA: 50%JNJ: 50%
100% JNJ50/50100% CYBA
Portfolio after 10yr
$67405916.07M
Annual income
$11,167,486,637,226.85/yr
Blended yield
16.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CYBA
No analyst data
Altman Z
0.1
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBA buys
0
JNJ buys
0
No recent congressional trades found for CYBA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBAJNJ
Forward yield40000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR-50%5.8% ✓
Portfolio after 10y$134811832.13M ✓$20.0K
Annual income after 10y$22,334,973,273,625.93 ✓$827.78
Total dividends collected$119366907.07M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CYBA vs JNJ ($10,000, DRIP)

YearCYBA PortfolioCYBA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,010,700$2,000,000.00$10,676$355.77+$2.00M → CYBA
2$190,067,337$187,915,887.85$11,407$389.39+$190.06M → CYBA
3$8,503,980,700$8,300,608,649.25$12,198$426.53+$8503.97M → CYBA
4$182,643,794,105$173,544,534,756.69$13,056$467.62+$182643.78M → CYBA
5$1,937,154,810,107$1,741,725,950,414.48$13,987$513.12+$1937154.80M → CYBA
6$10,705,034,441,357$8,632,278,794,542.14$14,998$563.56+$10705034.43M → CYBA
7$33,745,688,276,271$22,291,301,424,018.98$16,098$619.52+$33745688.26M → CYBA
8$68,944,009,367,743$32,836,122,912,133.60$17,295$681.69+$68944009.35M → CYBA
9$105,118,559,677,582$31,348,469,654,096.81$18,599$750.82+$105118559.66M → CYBA
10$134,811,832,128,639$22,334,973,273,625.93$20,022$827.78+$134811832.11M → CYBA

CYBA vs JNJ: Complete Analysis 2026

CYBA — Stock

Canyon Bancorp was founded in 2006 and is based in Palm Springs, California.

Full CYBA Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CYBA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBA vs SCHDCYBA vs JEPICYBA vs OCYBA vs KOCYBA vs MAINCYBA vs ABBVCYBA vs MRKCYBA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.